SciClone Pharmaceuticals reported earnings results for the third quarter ended September 30, 2016. For the quarter, the company reported revenues of $40.5 million, compared to $42.9 million for the same period in 2015. GAAP diluted net income per share of $0.19, compared to GAAP diluted net income per share of $0.23 for the same period in 2015. Non-GAAP diluted net income per share of $0.24, compared to $0.26 for the same period in 2015.